Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
#2271 Effects of Multi-Receptor Targeting Drugs in Neuroendocrine Tumors Using 3D Cell Culture
Introduction: Symptom control in functioning neuroendocrine tumors(NETs) may be difficult in some cases, thus, new therapeutic options, including multi-receptor targeting drugs are required.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Herrera-Martínez A
Authors: Herrera-Martínez A, Van Dungen R, Van Koetsveld P, Dogan-Oruc F, Culler M,
Keywords: NETs, somatostatin receptors, dopamine receptors, multi-receptor targeting drugs, hormone secretion,
Introduction: Although somatostatin receptor subtype 2 (SSTR2) and dopamine type 2 receptor (D2R) are reported to be expressed in neuroendocrine neoplasms (NEN), there is a lack of data from studies on a large number of patients with pancreatic NEN.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Lee L
Authors: Lee L, Ito T, Kawabe K, Otsuka T, Nakamura M,
Keywords: Somatostatin receptor, dopamine receptor, SSTR2, D2R,
Introduction: The mTOR pathway and dopamine receptors are potential targets for treatment of neuroendocrine tumors (NET).
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author: Sarnataro M
Authors: Sarnataro M, Pivonello C, De Martino M, Sciammarella C, Cuomo G,
Introduction: Expression of somatostatin receptors (SSTRs) and dopamine receptor 2 (DR2) in neuroendocrine tumors is of clinical importance, as they represent potential targets for diagnosis and treatment.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author:
Authors: Kanakis G, Grimelius L, Spathis A, Tringidou R, Rassidakis G,
Keywords: lung, carcinoid, somatostatin ,
Introduction: Expression of somatostatin receptors (SSTRs) and dopamine 2 receptor (D2R) in neuroendocrine tumors is of clinical importance, as somatostatin analogues and dopamine agonists are used in biotherapy.
Conference: 8th Annual ENETSConcerence (2011)
Presenting Author:
Authors: Kanakis G, Grimelius L, Trigidou R, Kaltsas G, Tsolakis A,
Keywords: somatostatin receptor subtypes, dopamine receptor 2, lung carcinoids,